https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-rare-type-non-cancerous-tumors
The FDA approved Ogsiveo tablets for adult patients with progressing desmoid tumors who require systemic treatment.
Create an account or login to join the discussion